CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 64  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0983
LYS 10.0188
GLU 20.0475
LEU 30.0193
ARG 40.0117
CYS 50.0155
GLN 60.0234
CYS 70.0462
ILE 80.0983
LYS 90.0491
THR 100.0185
TYR 110.0342
SER 120.0257
LYS 130.0607
PRO 140.0453
PHE 150.0216
HIS 160.0298
PRO 170.0043
LYS 180.0119
PHE 190.0140
ILE 200.0139
LYS 210.0116
GLU 220.0109
LEU 230.0088
ARG 240.0103
VAL 250.0094
ILE 260.0110
GLU 270.0146
SER 280.0196
GLY 290.0262
PRO 300.0236
HIS 310.0129
CYS 320.0106
ALA 330.0190
ASN 340.0174
THR 350.0126
GLU 360.0109
ILE 370.0118
ILE 380.0043
VAL 390.0056
LYS 400.0084
LEU 410.0098
SER 420.0072
ASP 430.0134
GLY 440.0072
ARG 450.0128
GLU 460.0166
LEU 470.0271
CYS 480.0152
LEU 490.0107
ASP 500.0146
PRO 510.0121
LYS 520.0652
GLU 530.0231
ASN 540.0122
TRP 550.0137
VAL 560.0104
GLN 570.0137
ARG 580.0139
VAL 590.0080
VAL 600.0108
GLU 610.0125
LYS 620.0160
PHE 630.0187
LEU 640.0247
LYS 650.0376
ARG 660.0224
ALA 670.0101
GLU 680.0630
ASN 690.0684

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.